Luka Bevanda, Valerie Mok, Kenny Lin, Deborah Assayag, Jolene H Fisher, Kerri A Johannson, Nasreen Khalil, Martin Kolb, Helene Manganas, Veronica Marcoux, Mohsen Sadatsafavi, Alyson W Wong, Christopher J Ryerson
RATIONALE: A visual analogue scale (VAS) is a simple and easily administered tool for measuring impact of disease; however, little is known about the use of a Dyspnea VAS in interstitial lung disease (ILD). OBJECTIVE: To validate the use of a Dyspnea VAS in a large and heterogenous cohort of patients with fibrotic ILD, including its minimal clinically important difference (MCID), responsiveness to change, and prognostic significance. METHODS: Patients with fibrotic ILD were identified from a large prospective registry...
February 5, 2024: Annals of the American Thoracic Society